Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of stomachic pill with cyperus and amomum

A technology for nourishing the stomach and allergic rhinitis with fragrant sand, which is applied in the field of medicine and can solve problems such as difficult to cure, weakened labor capacity, and unsatisfactory curative effect

Inactive Publication Date: 2007-10-10
GUANGDONG PHARMA UNIV
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Allergic rhinitis, also known as allergic rhinitis, is an allergic disease of the nasal mucosa. The main symptoms are nasal itching, continuous attacks of paroxysmal sneezing, a large amount of clear watery nasal discharge, and various complications. The main pathogen is inhalation Substances, food, contact objects; Asthma is recognized by the world medical community as one of the four chronic diseases, and is listed as the top ten causes of death. It is a disease that seriously endangers people's physical and mental health and weakens their ability to work, and it is difficult to be cured
These two kinds of respiratory system are common and frequently-occurring diseases, with prevalence rates of about 10% and 1-2% respectively. They have common pathological and clinical features. At present, it has been confirmed internationally that the two diseases belong to the same respiratory disease. The treatment methods and drugs There are also many, most of which are symptomatic treatments, such as corticosteroids, receptor antagonists, and membrane stabilizers. There are only a few etiological treatments, such as desensitization therapy and immunomodulators such as Siqikang, but the curative effects are not ideal
[0003] For a long time, people have paid attention to the role of diet in the pathogenesis of allergic rhinitis and asthma because of food allergy. The usual dietary treatment measures are to exclude specific allergic foods, such as: shrimp, crab, milk, etc. However, these factors account for the pathogenesis of allergic rhinitis and asthma. The overall proportion is low, and there is no direct correlation with the overall prevalence increase
Food allergy is only in which protein plays a role, while other food components including fat, carbohydrates, vitamins, trace elements, etc. and their proportional relationship have been neglected in the onset of allergic rhinitis and asthma. Through a series of studies, it was found that allergic The incidence of rhinitis and asthma is closely related to dietary non-allergic factors, and it has been confirmed from evidence-based medicine, epidemiology and experiments, which proves that treating allergic rhinitis and asthma from the digestive tract has become an important trend. However, there is no pharmaceutical preparation for the treatment of the disease from the perspective of the digestive tract

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] In order to better understand the present invention, the Xiangsha Yangwei Pill is used to carry out clinical application experiments on allergic rhinitis and asthma diseases, and to illustrate its new application in the preparation of drugs for treating allergic rhinitis and asthma.

[0009] Example Xiangsha Yangwei pills are examples of direct application of existing oral preparations such as granules, tablets, and oral liquids in the pharmaceutical market.

[0010] 1. Experimental method: adopt randomized controlled experiment method

[0011] A total of 80 outpatients with allergic rhinitis in the hospital met the diagnostic criteria for perennial allergic rhinitis formulated by the Chinese Medical Association. They were randomly divided into two groups, 41 cases in the treatment group and 39 cases in the control group. In the treatment group of Xiangsha Yangwei Pills, there were 21 males and 19 females, aged 14-57 years, with an average of 29.7±10.6 years, and the c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of Chinese medicine 'Stomach-nouring Xiansha pill' in preparing the medicines for treating allergic rhinitis and asthma is disclosed.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the application of Xiangsha Yangwei Pills in the preparation of medicines for treating respiratory diseases, especially allergic rhinitis and asthma. Background technique [0002] Allergic rhinitis and asthma are common respiratory diseases. Allergic rhinitis, also known as allergic rhinitis, is an allergic disease of the nasal mucosa. The main symptoms are nasal itching, continuous attacks of paroxysmal sneezing, a large amount of clear watery nasal discharge, and various complications. The main pathogen is inhalation Substances, food, contact objects; Asthma is recognized by the world medical community as one of the four chronic diseases, and is listed as the top ten causes of death. It is a disease that seriously endangers people's physical and mental health and weakens the ability to work, and it is difficult to be cured. These two kinds of respiratory system are common and frequentl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K9/20A61P11/02A61P11/06A61P37/08
Inventor 郭姣程靖郭彤
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products